International Parkinson and Movement Disorder Society
MDS Podcast
Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors.
Glöm inte att besöka poddens webbplats och stötta skaparen: www.movementdisorders.org
Skapare
International Parkinson and Movement Disorder Society
Kategori
Poddens webbplats
Senaste avsnittet
16 nov 2026
Var kan du lyssna?
Poddar i appen Replaio Radio Kommer snartPoddar kommer snart till appen. Installera nu och bli först med att uppleva ett helt nytt sätt att lyssna på poddar
Avsnitt
Award Article: Long duration levodopa response and neuroplasticity in Parkinson’s disease 31.08.2023
In this special issue celebrating the Movement Disorders journal Research Article of the Year 2023, Sara Schaefer discusses with Dr. Mario Zappia the effects of the short vs long duration responses to levodopa on cortical excitability and neuroplasticity in response to motor learning tasks in early Parkinson’s disease patients. Read the article »
Award Article: Have we forgotten what tics are? 31.08.2023
In this special issue celebrating the Movement Disorders Clinical Practice journal Research Article of the Year 2023, Sara Schaefer discusses tic phenomenology in primary tic disorders vs. functional tic-like disorders with Dr. Tamara Pringsheim. Read the article »
Perry Disease 04.08.2023
Dr. Wszolek shares with Dr. Schaefer his extensive knowledge about the clinical, genetic, and pathological findings in Perry disease, a rare and likely underdiagnosed parkinsonian condition. Read the article.
Pleiotropy in Parkinson´s disease and Cancer: Is there an association between these entities? 24.07.2023
In this episode, Dr. Pierre-Emmanuel Sugier discusses the epidemiological associations between PD and cancers. While investigating several European GWAS databases, his group raised the conundrum whether cancer and Parkinson's disease share common risk factors. Read the article.
Parkin Maintains Robust Pacemaking in Human iPSC-derived A9 Dopaminergic Neurons 07.07.2023
In this episode, we interviewed Prof. Jian Feng about his most recent paper covering the role of parkin mutations in human A9 dopaminergic neurons and role they play in locomotor activities of early-onset PD. Journal CME is available until July 20, 2024 Read the article.
Getting involved in the MDS: a fruitful relationship 26.06.2023
In this episode, Michele Matarazzo highlights the relevance of our society for the field and its members, with special guest Njideka Okubadejo.
A cross-sectional study of PPMI participants using alpha-synuclein seed amplification as a biomarker 12.06.2023
In this episode Dr. Tiago Outeiro talks with Dr. Andrew Siderowf about the exciting new results in his most recent publication on alpha-synuclein seed amplification assay. Read the article.
Inflammation is an early feature of Parkinson's disease 29.05.2023
Dr. Michele Matarazzo interviews Dr. Talene Yacoubian on an article recently published on the Movement disorders journal that reveals increased inflammatory markers in recently diagnosed patients with Parkinson's disease without medication, suggesting the important role of inflammation from the early stages of the disease. Furthermore, inflammatory biomarkers are related to cognition. Journal CME...
Diagnosis of Late-Onset Wilson's Disease 15.05.2023
Dr. Christelle Nilles talks with Dr. Hugo Morales Briceno about the clinical presentations of Wilson’s disease patients with onset after 40 years and the challenges of diagnosing patients with atypical neurological manifestations. Read the article.
International Parkinson and Movement Disorder Society Mission and Structure 08.05.2023
Sara Schaefer discusses the history, inner workings, and vision of the International Parkinson and Movement Disorder Society with current MDS President Francisco Cardoso.
Deep brain stimulation in Parkinson's disease with cognitive impairment: real-world evidence 01.05.2023
Deep brain stimulation (DBS) has long been considered a risky procedure for people with Parkinson's disease and cognitive impairment. In this interview, Dr. Miocinovic presents real-world data, showing that DBS might be safe and useful in carefully selected patients with moderate cognitive impairment. Read the article.
History of Movement Disorders: The Finding of Alpha-Synuclein and Lewy Bodies 24.04.2023
In this History of Movement Disorders Special Episode, Prof. Tiago Outeiro interviews Prof. Maria Grazia Spillantini about integral work involved in discovering the role alpha-synuclein plays in the development of Lewy bodies. She discusses where the field is now and what questions young researchers should start asking.
Hot topic: The gut microbiome in Parkinson's 17.04.2023
In this special Hot Topics episode, Dr. Filip Scheperjans discusses what we know and what we don't yet know about the gut microbiome in Parkinson's disease, theories of influencing pathways within the gut-brain axis, and future directions for exploring and altering the gut microbiome in this patient population to impact disease.
Pathological Validation of 2022 MSA Criteria 10.04.2023
Sara Schaefer discusses with Dr. Eduardo de Pablo-Fernandez his recent paper in Movement Disorders providing retrospective pathological validation of the 2022 MDS MSA Criteria using specimens from the Queens Square Brain Bank. Read the article.
Walking through the falls: understanding gait with wearable sensors in Parkinson's disease 27.03.2023
In this paper, Dr. Vrustangkumar Shah and colleagues evaluated gait in patients with Parkinson's disease in the lab and in real life, with and without levodopa through wearable sensors. Some measures are able to discriminate fallers from non-fallers in PD. Read the article.
Targeting alpha synuclein in early Parkinson's disease. Clinical trials and future perspectives 20.03.2023
Two clinical trials with antibodies targeting alpha synuclein in early Parkinson's disease have been published in the New England Journal of Medicine. Anthony Lang and Gennaro Pagano, the first authors of the articles share the results and discuss the possible future perspectives with the MDS Podcast editor, Michele Matarazzo. Read the prasinezumab article. Read the cinpanemab article.
Dystonia Series: Current and future approaches to treatment of dystonia 13.03.2023
In part 5 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Jill Ostrem about current and future approaches to treatment of dystonia.
Dystonia Series: Unraveling the neural routes of dystonia 06.03.2023
In part 4 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Anna Sadnicka on the neural roots of dystonia.
Machine learning for drug repurposing: A novel approach to find new treatments for Parkinson's disease 27.02.2023
Dr. Matarazzo interviews Émeline Courtois about the recently published article on machine learning approach to discover marketed drugs that could have an impact on the development of Parkinson's disease. Interestingly, furosemide and adrenergic drugs showed a potential protective effect in this very large cohort. Journal CME is available until January 19, 2024 Read the article.
Dystonia Series: Genetic landscape of dystonia 20.02.2023
In part 3 of the Dystonia Special Series, Dr. Francesca Morgante interviews Prof. Carolyn Sue on the Genetic landscape of dystonia.
Clozapine in Parkinson's disease: Why, when and how? 13.02.2023
Clozapine is a antipsychotic drug that has been marketed for decades. In this interview, Dr. Friedman shares his thoughts on its utility in Parkinson's disease along with some practical advices on how to use it in the clinic. Read the article.
Dystonia Series: Beyond “torsion": non-motor features of dystonia 06.02.2023
In part 2 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Davide Martino on the non-motor features of dystonia.
Off-State Dyskinesias after GDNF Infusion in Parkinson's Disease 30.01.2023
Sara Schaefer speaks to Alan Whone of the University of Bristol on his retrospective analysis of off-state dyskinesias in Parkinson's disease patients who received serial infusions of GDNF into the putamen. Read the article.
Dystonia Series: Pearls on diagnosis and phenomenology 23.01.2023
In part 1 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Miryam Carecchio on pearls on diagnosis and phenomenology of dystonic syndrome.
Idiopathic Normal Pressure Hydrocephalus: Critical Review of Objective Findings 16.01.2023
Prof Martino points out the existent literature concerning the objective findings in the 3 cardinal domains of idiopathic normal pressure hydrocephalus. Read the article.
Liknande poddar
Replaio är ingen poddutgivare; programnamn, omslag och ljud tillhör sina upphovspersoner och distribueras via offentliga RSS-flöden